- Home
- ARTW vs EDSA Comparison
ARTW vs EDSA Comparison
Compare ARTW & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- EDSA
- Stock Information
- Founded
- ARTW 1956
- EDSA 2015
- Country
- ARTW United States
- EDSA Canada
- Employees
- ARTW N/A
- EDSA N/A
- Industry
- ARTW Industrial Machinery/Components
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- EDSA Health Care
- Exchange
- ARTW Nasdaq
- EDSA Nasdaq
- Market Cap
- ARTW 12.5M
- EDSA 12.8M
- IPO Year
- ARTW N/A
- EDSA N/A
- Fundamental
- Price
- ARTW $2.16
- EDSA $1.72
- Analyst Decision
- ARTW
- EDSA Strong Buy
- Analyst Count
- ARTW 0
- EDSA 2
- Target Price
- ARTW N/A
- EDSA $13.00
- AVG Volume (30 Days)
- ARTW 60.3K
- EDSA 907.9K
- Earning Date
- ARTW 10-07-2025
- EDSA 12-12-2025
- Dividend Yield
- ARTW N/A
- EDSA N/A
- EPS Growth
- ARTW N/A
- EDSA N/A
- EPS
- ARTW 0.49
- EDSA N/A
- Revenue
- ARTW $24,079,949.00
- EDSA N/A
- Revenue This Year
- ARTW N/A
- EDSA N/A
- Revenue Next Year
- ARTW N/A
- EDSA N/A
- P/E Ratio
- ARTW $5.56
- EDSA N/A
- Revenue Growth
- ARTW N/A
- EDSA N/A
- 52 Week Low
- ARTW $1.43
- EDSA $1.55
- 52 Week High
- ARTW $4.71
- EDSA $4.49
- Technical
- Relative Strength Index (RSI)
- ARTW 37.57
- EDSA 35.07
- Support Level
- ARTW $2.23
- EDSA $1.68
- Resistance Level
- ARTW $2.47
- EDSA $1.83
- Average True Range (ATR)
- ARTW 0.14
- EDSA 0.12
- MACD
- ARTW -0.01
- EDSA 0.00
- Stochastic Oscillator
- ARTW 9.80
- EDSA 27.03
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.